Back to Search
Start Over
Supplementary Table S1 from Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- CRISPR-Cas9 loss-of-function screens analysed in this study.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2b10b492e6d35497252e2893208eea48